AYOXXA Signs Research Agreement in the Field of Ophthalmology With One of the Leading Pharmaceutical Companies

January 7, 2019 10:45 AM

Agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology This collaboration reflects an initial phase of a multi study plan in the field of ophthalmology Further step to establish AYOXXA LUNARISTM system as the standard for biomarker identification and validation in translational...

Read more

Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business

January 7, 2019 7:11 AM

Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBI to Service the $250 Billion Global Biopharmaceuticals Market SOUTH EASTON, MA / ACCESSWIRE / January 7, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of enabling high pressure-based instruments, consumables, and related services for the worldwide life sciences...

Read more

Molecular Partners to Present at The 37th Annual J.P. Morgan Healthcare Conference

January 7, 2019 1:00 AM

Company to highlight recent progress on clinical DARPin® compounds, its oncology research strategy and to discuss the strategic collaboration with Amgen on MP0310 ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / January 7, 2019 / Molecular Partners AG (SWX: MOLN) (OTC PINK: MLLCF), a clinical-stage biotech company pioneering the use of DARPin® therapeutics* to treat serious diseases, today announced that it will present at the 37th Annual...

Read more

Shanghai-Based Hexaell Biotech Secures 50 million RMB ($7.3 million) Series A Financing From Hyfinity Investments

January 3, 2019 9:00 AM

The funding will be used to support the clinical and CFDA registration of the hiHep cell engineering system and further accelerate Hexaell's research and development in liver diseases and cell engineering pipeline SHANGHAI, CHINA / ACCESSWIRE / January 3, 2019 / Hexaell Biotechnologies Ltd, a Shanghai-based technology company specializing in bio-artificial liver organ based on hiHep cell engineering systems, closed the Series A round of 50...

Read more

Dyadic Announces Update Regarding Initial Form 10 Registration Statement Filing with SEC

January 2, 2019 6:05 PM

JUPITER, FL / ACCESSWIRE / January 2, 2019 / Due to the federal government shutdown, the Securities and Exchange Commission (the "Commission") has not completed its review of Dyadic International, Inc's. (OTCQX: DYAI) (the "Company") Registration Statement on Form 10-12G (File No. 000-55264), filed on November 5, 2018 (the "Registration Statement"). As a result, on January 2, 2019, the Company notified the Commission of its desire to prevent the...

Read more

Early Warning Report under National Instrument 62-103

December 31, 2018 9:00 AM

NORTH YORK, ON / ACCESSWIRE / December 31, 2018 / On December 19, 2018, Tree of Knowledge International Corp. (the "Corporation") completed an offer to purchase all of the outstanding securities of Asterion Bio Med Inc. ("Asterion") on the basis of 2.1894 common shares of the Corporation (the "Exchange Ratio") for each common share of Asterion (the "Offer"). As a result, Asterion became a wholly owned subsidiary of the Corporation. In addition...

Read more

ZIVO Nutritional Efficacy Study for Poultry is Successful, Confirms Production Methods and Health Benefits

December 19, 2018 9:55 AM

KEEGO HARBOR, MI / ACCESSWIRE / December 19, 2018 / ZIVO Bioscience, Inc. (OTCQB: ZIVO) a biotech/agtech R&D company engaged in the commercialization of nutritional products derived from its proprietary algal strains, announces today that preliminary data analysis from its most recent poultry nutritional efficacy study show positive results that confirm the successes of previous poultry efficacy studies conducted in partnership with...

Read more

Passage of U.S. Farm Bill a Major Milestone for EastWest’s Long Term Hemp Strategy

December 19, 2018 9:00 AM

EastWest BioScience Negotiating Major Strategic Hemp and CBD Opportunities. VANCOUVER, BC / ACCESSWIRE / December 19, 2018 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) is hopeful for an early Christmas present with continuing progress of the U.S. Farm Bill. The federal legalization of hemp in the US, once passed, opens up significant opportunities for EastWest to follow through on its long held strategic plans to market...

Read more

Major Cancer Research Center Reports Pressure BioSciences' PCT Platform Could Play Major Role in Improving Cancer Diagnosis and Treatment

December 18, 2018 9:32 AM

Publication Cites Significant Benefits from Using the PCT Platform in the Analysis of Cancer Tissue Biopsies SOUTH EASTON, MA / ACCESSWIRE / December 18, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries. The Company today announced that...

Read more

Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 19th at 4:30 PM EST

December 17, 2018 11:25 AM

Update to Include Discussions on Recent Progress, Accomplishments, and Enhancements in All Three Platform Technologies; Commercialization and Strategic Partnership Efforts; Personnel Changes; and Q42018 & FY2019 Guidance SOUTH EASTON, MA / ACCESSWIRE / December 17, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to provide an update on recent progress,...

Read more

Qrons Extends Services Agreement with Ariel University for Additional Year

December 17, 2018 9:00 AM

Agreement Will Facilitate Completion of First Candidate Product to Treat Traumatic Brain Injuries MIAMI, FL / ACCESSWIRE / December 17, 2018 / Qrons Inc. (OTC PINK: QRON) ("Qrons " or the "Company"), a preclinical biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on treating traumatic brain injuries ("TBIs"), announced today that it has renewed its Services Agreement with Ariel...

Read more

Eastwest BioScience Receives Multiple Purchase Orders with Global Retailer The TJX Companies Inc (NYSE: TJX) for Canada Wide Distribution

December 13, 2018 9:00 AM

VANCOUVER, BC / ACCESSWIRE / December 13, 2018 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that the Company is processing purchasing orders for its hemp based consumer goods through global retailer The TJX Companies, Inc (NYSE:TJX), the leading mass retailer of apparel and home fashions in the U.S. and worldwide. TJX is a global retail giant that has built a distinguishable and competitive brand with a strong...

Read more

American CryoStem to file Investigational New Drug Application with FDA

December 13, 2018 6:30 AM

EATONTOWN, NJ / ACCESSWIRE / December 13, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries, today announced that it has completed its Pre-IND discussions with the FDA concerning its ongoing work to file an Investigational New Drug Application (IND)...

Read more

Mymetics Virosomes Successful in Allergy Proof-of-Concept Study

December 13, 2018 2:00 AM

Success criteria met: Bet v 1 COP-virosomes showed no IgE induction, favorable TH1 response and were well tolerated in mice study Anergis has time limited exclusive option to license Mymetics' virosome technology in the field of allergies EPALINGES, SWITZERLAND / ACCESSWIRE / December 13, 2018 / Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life...

Read more

EastWest Announces Change of Directors

December 11, 2018 4:40 PM

VANCOUVER, BC / ACCESSWIRE / December 11, 2018 / EastWest Bioscience (formerly Harbour Star Capital Inc.) (the "Company" or "EastWest") (TSXV: EAST) announces that Mr. Mohammad Fazil has resigned as a director effective as of December 4, 2018, the Company wishes to thank Mr. Fazil for his years of service to Harbour Star Capital Inc. and assistance following completion of the qualifying transaction, as set out in the press release issued...

Read more

Molecular Partners’ R&D Day in New York highlights progress of pipeline of DARPin® therapeutic candidates and dedicated research focus areas

December 6, 2018 1:00 AM

The company announces plans to launch a second phase 2 clinical trial in multiple myeloma with MP0250, its proprietary lead asset in oncology Pamela Trail, the company's new CSO, highlights progress focusing the research team in several key areas, with the goal of producing a sustainable pipeline of DARPin® molecule IND candidates The company provides additional insight on its...

Read more

EastWest Bioscience Continues Expansion on the Canadian East Coast Through Agreement with Largest Pet Chain in Quebec

December 5, 2018 1:35 PM

VANCOUVER, BC / ACCESSWIRE / December 5, 2018 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) announces that it will soon have its premium pet brand Natural Pet Science available for purchase at Mondou, the largest pet retail chain in Quebec. Having the Natural Pet Science products available at Mondou is within Eastwest's overall sales strategy to expand its retail distribution across Canada toward the country's East Coast...

Read more

American CryoStem Receives Final Patent to Complete its Core Cellular Platform

December 4, 2018 6:00 AM

EATONTOWN, NJ / ACCESSWIRE / December 4 , 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries, today announced receipt from the USPTO of the Issue Notification for our Patent titled ''Systems and Methods for the Digestion of Adipose Tissue Samples from a Client...

Read more

PCT LTD Announces Successful Presentation of Annihilyzer(R) Hospital Infection Control Systems at APIC Event in South Carolina

November 29, 2018 7:30 AM

LITTLE RIVER, SC / ACCESSWIRE / November 29, 2018 / PCT LTD (OTC Pink: PCTL), a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, recently attended the South Carolina Association for Professionals in Infection Control and Epidemiology (APIC) event in Columbia, SC. PCT introduced attendees to the new Annihilyzer® Infection Control System during the event. The response from the attendees was positive...

Read more

Quanta Inc. to Present at the 11th Annual LD Micro Main Event

November 28, 2018 11:00 AM

LOS ANGELES, CA / ACCESSWIRE / November 28, 2018 / Quanta Inc. (OTC PINK: QNTA), an applied bio-science company announced today that it will be presenting at the 11th Annual LD Micro Main Event. The conference is being held on December 4-6, 2018 at the Luxe Sunset Blvd Hotel in Los Angeles. Event: 11th Annual LD Micro Main Event Location: Luxe Sunset Blvd Hotel, Los Angeles Date: December 5, 2018 -- 2:00 PM PST Mr. Eric Rice, CEO and Founder of...

Read more